Kenichi Hashimoto

5PUBLICATIONS
21CO-AUTHORS
Epidemiological modellingEpidemiological methodsRegenerative medicine (incl. stem cells)Predictive and prognostic markersPacific Peoples medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Correction: Akiyama et al. Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan. J. Clin. Med. 2025, 14, 4697.

|Jul 12, 2025
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan.

Shoko Akiyama, Kenji Oda, Hiroko Mizohata

|Mar 13, 2025
Effectiveness of Switching from Multiple-Inhaler to Once-Daily Single-Inhaler Triple Therapy in Patients with COPD in a Real-World Setting in Japan.

Gema Requena, Lucinda J Camidge, Alexander Ford

|Dec 13, 2023
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.

Alexandrosz Czira, Shoko Akiyama, Takeo Ishii

|Jul 13, 2023
Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan.

Paul Jones, Osamu Hataji, Yoshimi Suzukamo

Pageof 1

Frequent Collaborators

3 joint publications

Shoko Akiyama

2 joint publications

Natsuki Sasakura

2 joint publications

Takeo Ishii

2 joint publications

Hiroko Mizohata